Write in a clean editor, then format for JNCI Monographs in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JNCI Monographs is a peer-reviewed journal published by Oxford University Press, covering Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, Cancer survivorship and care.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', JNCI Monographs, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — JNCI Monographs has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Global Cancer Incidence and Screening Breast Cancer Treatment Studies Cancer survivorship and care Health Systems, Economic Evaluations, Quality of Life Economic and Financial Impacts of Cancer |
| ISSN | 1052-6773 |
| Citation impact (2-yr) | 5.37 |
| h-index | 107 |
| i10-index | 515 |
| Total citations | 45,526 |
| Top institutions publishing here | National Cancer Institute |
| Journal website | jncicancerspectrum.oupjournals.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Depression is the psychiatric syndrome that has received the most attention in individuals with cancer. The study of depression has been a challenge because symptoms occur on a broad spectrum that ranges from sadness to major affective disorder and because mood change is often difficult to evaluate when a patient is confronted by repeated threats…
National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-18 was initiated in 1988 to determine whether four cycles of doxorubicin/cyclophosphamide given preoperatively improve survival and disease-free survival (DFS) when compared with the same chemotherapy given postoperatively. Secondary aims included the evaluation of preoperative chemotherapy in downstaging the primary breast tumor and involved axillary lymph…
Cervical cancer remains the second most common cancer in women worldwide and the most frequent in developing countries. Pre-neoplasic cervical lesions represent an additional burden in countries where screening is widespread. The human papillomavirus (HPV) prevalence and type distribution in normal smears and in cancer specimens are being described and show relatively small international variation.…
Individual patient data were available for all four of the randomized trials that began before 1995, and that compared adjuvant radiotherapy vs no radiotherapy following breast-conserving surgery for ductal carcinoma in situ (DCIS). A total of 3729 women were eligible for analysis. Radiotherapy reduced the absolute 10-year risk of any ipsilateral breast event (ie, either…
It is now well established that infection with oncogenic human papillomavirus (HPV) types is the necessary cause of cervical cancer (CC) and its immediate precursor cervical intraepithelial neoplasia 3. However, HPV infection alone may not be sufficient to cause CC, and other exogenous and endogenous factors may exist that, in conjunction with HPV, influence the…
